Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc. (SBFMW) Stock Overview

Explore Sunshine Biopharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SBFMW●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.03
$0.02(37.68%)
U.S. Market opens in 54h 53m

Sunshine Biopharma, Inc. (SBFMW)

Meyka AI Score

Z

Key Financials

Market Cap155.7K
P/E Ratio-0.11
EPS (TTM)$-11.30
ROE-0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.01
3 Months$0.00
1 Year Target$0.01

SBFMW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Sunshine Biopharma, Inc. (NASDAQ: SBFMW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sunshine Biopharma, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SBFMW on the NASDAQ shows an RSI of 44.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.01 for the NASDAQ listing.

Key metrics behind Sunshine Biopharma, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.11 and a market capitalization of 155.7K. Combined with our AI analysis, these give both institutional and retail investors a clear view of SBFMW on the NASDAQ.

Price Performance (NASDAQ: SBFMW)

1-Day Change
-37.68%
5-Day Change
-27.51%
1-Month Change
-3.42%
3-Month Change
-71.75%
6-Month Change
-83.63%
Year-to-Date (YTD) Change
-81.98%
1-Year Change
-80.56%
3-Year Change
-90.28%
5-Year Change
-94.82%
All-Time (Max) Change
-94.82%

Contact Information

https://www.sunshinebiopharma.com
332 216 1147
333 Las Olas Way, Fort Lauderdale, FL, 33301

Company Facts

500 Employees
IPO DateFeb 15, 2022
CountryUS
Actively Trading

Frequently Asked Questions